Deerfield Management’s Starling Oncology Warrant STLNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51K Hold
1,250,000
– – ﹤0.01% 80
2026
Q1
$54.8K Hold
1,250,000
– – ﹤0.01% 78
2025
Q4
$151K Hold
1,250,000
– – ﹤0.01% 144
2025
Q3
$150K Hold
1,250,000
– – ﹤0.01% 143
2025
Q2
$64.1K Hold
1,250,000
– – ﹤0.01% 116
2025
Q1
$33.9K Hold
1,250,000
– – ﹤0.01% 119
2024
Q4
$6.5K Hold
1,250,000
– – ﹤0.01% 105
2024
Q3
$25K Hold
1,250,000
– – ﹤0.01% 440
2024
Q2
$32.9K Hold
1,250,000
– – ﹤0.01% 428
2024
Q1
$250K Hold
1,250,000
– – ﹤0.01% 295
2023
Q4
$250K Hold
1,250,000
– – ﹤0.01% 147
2023
Q3
$115K Hold
1,250,000
– – ﹤0.01% 80
2023
Q2
$34.9K Hold
1,250,000
– – ﹤0.01% 95
2023
Q1
$81.4K Hold
1,250,000
– – ﹤0.01% 96
2022
Q4
$138K Hold
1,250,000
– – ﹤0.01% 93
2022
Q3
$691K Hold
1,250,000
– – 0.01% 109
2022
Q2
$625K Hold
1,250,000
– – 0.01% 107
2022
Q1
$1.44M Hold
1,250,000
– – 0.03% 100
2021
Q4
$863K Hold
1,250,000
– – 0.02% 114
2021
Q3
$2.01M Hold
1,250,000
– – 0.04% 120
2021
Q2
$2.16M Hold
1,250,000
– – 0.04% 138
2021
Q1
$1.69M Buy
+1,250,000
New +$2.32M 0.04% 128

Other funds holding STLNW

Deerfield Management's STLNW Position: Q2 2026 in Review

Deerfield Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 1,250,000 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #80.

Deerfield Management first reported a position in STLNW in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.16M in Q2 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

  • Deerfield Management held 1,250,000 shares of Starling Oncology Warrant worth $51K as of Q2 2026.
  • Deerfield Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
  • Starling Oncology Warrant made up ﹤0.01% of Deerfield Management's portfolio in Q2 2026, its #80 holding.
  • Deerfield Management first reported a position in Starling Oncology Warrant in Q1 2021 and has held it in 22 quarters since.
  • Deerfield Management's Starling Oncology Warrant position peaked at $2.16M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.